Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-14

Clinical Trial Update: Oro-tracheal Intubation: Flurbiprofen Subglottic Instillation to Prevent Laryngeal Inflammation [Phase 2]

View source ↗

Summary

Phase 2 trial update on using flurbiprofen instillation in the trachea to prevent laryngeal inflammation after Oro-tracheal intubation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Flurbiprofen (flurbiprofen)

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: D010612 | Phase 2 | Status: UNKNOWN